TetraGenetics

TetraGenetics is a biopharmaceutical company developing new therapies for autoimmune diseases, using proprietary technology (TetraExpress™) to discover macromolecular drugs targeting ion channel membrane proteins. The company’s drug discovery focus is on novel biologics for autoimmune diseases and pain.